Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $5 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.